Astec LifeSciences 32nd AGM notice and Annual Report 2025-26 filed

Pat NegativeResults View source PDF Explain this filing

ASTEC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.5%Reaction day

₹670.00

prior close

₹677.20

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.9%+0.6% vs market

Pesticides & Agrochemicals peers, median of 28sector+0.6%+2.0% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 2.0 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.5

10m

+0.3

15m

+0.1

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.5+1.9+0.6+0.6+2.0

Next day

+2.9+3.3-0.4+2.0+1.0

+2.6+3.5-0.8+2.2+0.4

+1.9+2.4-0.5+1.9+0.0

+2.2+3.1-0.8+2.2+0.0

+5.0+2.6+2.4+1.9+3.1

+3.1+2.1+1.0+2.8+0.4

15d

-5.5+0.9-6.4+3.2-8.8

-7.8+5.5-13.3+1.9-9.7

+14.4+8.1+6.3-4.5+18.9

+8.6+3.5+5.2-15.9+24.5

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Astec LifeSciences filed its Annual Report 2025-26 along with notice for the 32nd AGM on July 31, 2026 at 4 PM via video conferencing. Book closure runs July 26-30, 2026 with remote e-voting cutoff on July 24. FY25-26 sales rose to about Rs 448 crore from Rs 381 crore; EBITDA reached near break-even at Rs 0.5 crore versus a loss of Rs 60.6 crore earlier. Net loss narrowed to about Rs 81 crore from Rs 135 crore. EPS remained negative at minus Rs 37.79.

Likely market impact

AGM is procedural. Company is still loss-making though losses are narrowing and revenue is recovering. Shareholders await a return to profitability.